55
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Idiopathic Myelofibrosis Associated with Ulcerative Colitis

, , , &
Pages 1481-1483 | Published online: 01 Jul 2009

  • Barosi, B. (1999) "Myelofibrosis with mycloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines", J. Clin. Oncol. 17, 2954-2970.
  • Tefferi, A. (2000) "Myelofibrosis with myeloid melaplasia", N Engt. J. Med. 342, 1255-1265.
  • Goixdon, B., Coleman, M., Kohen, P. and Day, N.K. (1981) "Immunologie abnormalities in myelofibrosis with activation of the complement system". Blood 58, 904-910.
  • Rondeau, E., Solal-Celigny. P., Dbermy, D., et al, (1983) "Immune disorders in agnogenic myeloid metaplasia: relations with myelofibrosis". Br. J. Haematol. 53, 467-475.
  • Lewis, C.M. and Pegrum, G.D. (1978) "Immune complexes in myelofibrosis: a possible guide to management", Br. J. Haematol. 39, 233-239.
  • Caligaris-Cappio, F., Vigliani. R., Novarino. A., Camussi, G., Campana, D. and Oavoslo. F. (1981) "Idiopathk myelofibrosis: a possible rule for immune-complexes in the pathogenesis of bone marrow fibrosis", Br. J. Haematol. 49, 17-21.
  • Seelen, M.A., de Meijer, P.M., Posthuma, E.F. and Meinders, A.B. (1997) "Myelofibrosis and idiophatic throtnbocytopenic purpura", Ann. Hematol. 75, 129-131.
  • Paquette. R.L., Meshkinpour, A. and Rosen, P.J. (1994) "Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus". Medicine (Bultim.) 73, 145-152.
  • Bass, R.D., Pullarkat, V., Feinstein, D.I., Kaut. A., Winberg, C.D. and Brynes. R.K. (2001) "Pathology of autoimmune myelofibrosis. A report of three cases and a review of the literature". Am. J. Clin. Pathol. 116, 211-216.
  • Rovira, M., Lopez-Guillermo, A., Cervantes, F., Montserrat, E. and Rozman, C. (1990) "Scleroderma associated with idiopathic myelofibrosis", Leuk. Lymphoma 1, 153-155.
  • Hernández-Boluda, J.C., Rosiñol. L., Ferrer, A. and Cervantes, F. (2002) "Idiopathic myelofibrosis associated with primary biliary cirrhosis", Leuk. Lymphoma 42(3), 673-674.
  • Cervantes, F., Pereira, A., Marti, J.M., Feliu, E. and Rozman. C. (1988) "Bone marrow lymphoid nodules in myeloproliferativc disorders: association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significance". Br. J. Haematol 70, 279-282.
  • Cervantes. F., Hernández-Boluda. J.C., Villamor, N-. Serra, A. and Montserrat, E. (2000) "Assessment of peripheral blood lymphocyte subsets in idiopathic myelofibrosis", Eur. J. Haematol. 65, 104-108.
  • Ben-Chetrit, E., Gross. D.J., Okón, E. and Levo. Y. (1983) "The association between autoimmunity and agnogenic myeloid metaplasia". Scand. J. Haematol. 31, 410-412.
  • Taskapan, H., Gürsoy, S., Cetin, M., Oymak, O. and Özbakir, Ö+00D6. (2001) "Development of dermatomyositis in a patient with primary myelofibrosis", Hematology 6, 131-134.
  • Marie, I., Levesque, H., Cailleux, N., et al., (1999) "An uncommon association: Sjögrens syndrome and autoimmune myclofibrosis", Rheumatology 38, 370-382.
  • Lee, S.C., Yun, S.J., Lee, J.-B., Lee. S.-S. and Won, Y.H. (2001) "A case of porphyria cutanea larda in association with idiophatic myclofibrosis and CREST syndrome". Br. J. Dermatol. 144. 182-185.
  • Ros. S., Rodriguez. J., Carapoy. E. and Roig, D. (1994) "Mielofibrosis idiopática asociada a la artritis reumatoide", Med. Clin. (Barcelona) 102, 277.
  • Aharon, A., Levy, Y., Bar-Dayan. Y., et al., (1997) "Successful treatment of early secondary rayelofibrosis in SLE with IVIG", Lupus 6, 408-411.
  • Özsoylu, S., Ruacan, S., Karaaslan, Y. and Dýndar, S. (1991) "Mega-dose intravenous methylprednisolone in adult idiopathic myelofibrosis". Hematol. Rev. 5, 121-128.
  • Podolsky, D.K. (1991) "Inflammatory bowel disease", N Engl. J. Med. 325, 928-936
  • Brandlzaeg, P. (1995) "Autoimniututy and ulcerative coutis: can two enigmas make sense together?", Gastroenterology 109. 307-312.
  • Snook, L.A., dc Silva, H.J. and Jewell, D.P. (1989) "The association of autoimmune disorders with inflammatory bowel disease". Q J. Med. 72, 835-840.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.